S21.F S2MEDICAL AB B

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
0.0002 EUR
Close of Nov 8, 2026
0.0001 0.0041
Market cap
EUR 250K
P/E
-
P/B
0.27x
ROE
7.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is S21.F undervalued?

Graham number

The Graham number of S2MEDICAL AB B cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

S2MEDICAL AB B fundamental analysis

No fundamental analysis for S2MEDICAL AB B yet.

S2MEDICAL AB B stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About S2MEDICAL AB B

S2Medical AB (publ) develops products for wound healing, infection control, and cosmeceuticals spectrum in Sweden. The company offers odor eliminator under the YNOLENS brand; IvaQ, a negative pressure wound therapy (NPWT) system; Instagraft, a technology designed to make skin transplantation even in non-specialist healthcare setting; ADMERCIN, a solution against antibiotic-resistant bacteria; and Epiprotect, a technology designed to protect and support wound healing by creat…

Full company profile